Project Details
Description
A Phase 3 Clinical Trial to evaluate the Safety and Efficacy of Treatment with 2mg Intralesional Allovectin-7 in Malignant Melonoma Compared to...
| Status | Finished |
|---|---|
| Effective start/end date | 7/27/06 → 4/30/09 |
Funding
- VICAL INCORPORATED
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.